Navigation Links
Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

Studies Show ABT-263 and ABT-869 to be Promising in Targeting Cancer Cells'

Underlying Mechanisms

ABBOTT PARK, Ill., May 15 /PRNewswire-FirstCall/ -- Abbott scientists will highlight the latest clinical trial data of several investigative compounds in the company's oncology pipeline at this year's American Society of Clinical Oncology (ASCO) Annual Meeting, scheduled for May 30 in Chicago. The presentations include ABT-263, a Bcl-2 family protein antagonist, and ABT-869, an oral small molecule that provides simultaneously potent and specific inhibition of the VEGFR and PDGFR families. Both compounds were discovered by Abbott scientists and are being co-developed by Abbott and Genentech. The company's meeting abstracts are available online today at http://www.asco.org.

By targeting a key survival mechanism of cancer cells, Abbott scientists identified ABT-263 as a potent inhibitor of Bcl-2 family proteins. The Bcl-2 family proteins regulate apoptosis (programmed cell death), the natural process by which damaged or unwanted cells die and are cleared from the body. When this process is defective, damaged cells can continue to divide, leading to the formation and growth of tumors. Preclinical studies showed promising activity against chronic lymphocytic leukemia (CLL), lymphomas and small cell lung cancer -- Phase I/II trials are currently underway in these diseases.

Additionally, Abbott scientists are targeting another vital characteristic of cancer cells with ABT-869. In early studies, data have shown that ABT-869 inhibits a distinct set of kinases that are involved in angiogenesis, a process by which tumors gain access to new blood vessels. Inhibition of these kinases may suppress tumor growth by cutting off tumor blood supply. ABT-869 is currently being tested against several tumor types in Phase II clinical trials.

"Researchers from around the world have requ
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Citi Investment Research Global Health Care Conference
2. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
4. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
5. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
6. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
7. Abbott Hosts Conference Call for First-Quarter Earnings
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
10. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
11. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Top medical tourism firm, VisitandCare.com, is ... ongoing commitment to providing superior patient experiences. Ojas ... with the best possible experience for a comprehensive range ... , Executives at Ojas Aesthetic Clinic persistently assert that, ... nothing about you, without you — through transparent engagement ...
(Date:4/21/2015)... Angelo’s FabriClean has recently announced that the company ... avail the area rug cleaning services. Area rug cleaning ... equipments, making use of the quick drying technique to ... pressure steam extraction to clean even the most stubborn ... made with delicate fabric. , “Good maintenance and ...
(Date:4/21/2015)... Somerset, NJ & New York, NY (PRWEB) April ... the leading global provider of advanced delivery technologies ... health products, today announced the launch of ADVASEPT™ ... the safe and efficient delivery of injectable medications. ... syringe, combining a safe, convenient and functional container ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 QuickMedical, ... equipment and supplies, now represents Schiller America's ... Monitors, ECGs, Stress Tests, and Vital Signs Monitors, ... in Switzerland, is a global leader in the ... products are developed in close cooperation with the ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Global Sodium Citrate Industry is a professional and ... global Sodium Citrate Market with a ... companies included in the sodium citrate market research ... Acid Chemicals, Natural Biological, Cofco Biochemical, Capchem, Lianyungang ...
Breaking Medicine News(10 mins):Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 2Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 3Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3
... phase of the illness, study says , , WEDNESDAY, Sept. 12 ... the manic phase of bipolar disorder, and works faster than ... a new study has found. , "One of the problems ... have this long period before they start to work," explained ...
... Chance to Help Make a Difference & Join ... N.C., Sept. 12 This fall, Pink is the color,of ... its,14th anniversary in the battle against Breast Cancer September 20 ... to save lives by,purchasing a new 25% Pink Savings Card. ...
... CDH plans continue to grow in popularity among ... Employees who fear high,out-of-pocket costs aren,t blocking the ... and employers take advantage of,money-saving options as healthcare ... Consulting Worldwide, the global human capital consulting,organization of ...
... prevailing issue in the United States, with millions of ... that Pycnogenol, (pic-noj-en-all), an antioxidant plant extract from the ... in children. The study shows Pycnogenol balances stress hormones, ... of ADHD. , The findings, to be published ...
... the days of Hippocrates, people have known that certain ... researchers have learned that these cyclic recurrences of disease, ... In order to accurately predict when outbreaks of disease ... Elena Naumova, PhD, associate professor in the Department of ...
... LOS GATOS, Calif., Sept. 12 Death may be the ... about. It is usually looked,upon as something to fear -- ... Darlyne intend to tear down the walls. "Triumph" is ... Philip,and Darlyne clarified and expressed their feelings about Darlyne,s,impending death ...
Cached Medicine News:Health News:Tamoxifen Helps Treat Bipolar Disorder 2Health News:Tamoxifen Helps Treat Bipolar Disorder 3Health News:Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer 2Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 2Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 3Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 4Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 5Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 6Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 7Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 8Health News:New study: Pine bark extract reduces ADHD symptoms in children 2Health News:Mathematics might save you a trip to the ER 2Health News:'Triumph' -- Traveling Towards Death: Preparing for a New Life 2
(Date:4/21/2015)... NEW YORK , April 21, 2015 ... Summary Sepsis is a life-threatening complication arising ... to the infection damages its own tissues and organs. ... common among children <1 year of age, ... Clinic, 2014). Global estimates for the year 2013 showed ...
(Date:4/21/2015)... SAN DIEGO , 21. April 2015 ... Software für die quantitative Analyse des Hirnvolumens ... AG, einem weltweiten Pharmaunternehmen, bekannt geben zu ... des leistungsstarken NeuroQuant-Quantifizierungsreports des Hirnvolumens zusammenarbeiten, der ... von Hirnvolumen in Patienten mit multipler Sklerose ...
(Date:4/21/2015)... InfuSystem Holdings, Inc. (NYSE MKT: INFU), a ... for the healthcare industry in the United ... announces today that it has closed the acquisition by ... Ciscura Holding Company, Inc., and its subsidiaries.  Ciscura, based ... privately-held Southeastern regional provider of ambulatory infusion pumps and ...
Breaking Medicine Technology:EpiCast Report: Sepsis - Epidemiology Forecast to 2023 2EpiCast Report: Sepsis - Epidemiology Forecast to 2023 3CorTechs Labs kündigt Partnerschaft für die Bereitstellung umfassender Lösungen zur Quantifizierung des Verlustes von Hirnvolumen bei multipler Sklerose an 2InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 2InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 3InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 4
... Dec. 21, 2011  Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE)("Ampio" or ... uses for previously approved drugs and new molecular entities ... agreements with accredited investors to sell an aggregate approximately ... $0.0001 per share (the "Shares"), at a price per ...
... Dec. 21, 2011 At a ceremony coinciding with ... Johnson,s public revelation that he had acquired HIV, the ... acknowledged Waters Corporation (NYSE: WAT ) for ... liquid chromatograph/mass spectrometer that will be used to build ...
Cached Medicine Technology:Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 2Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 3Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 2Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 3Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 4
Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an ...
... The IEC CL40 and FL40 Centrifuge ... safety and versatility to increase your ... a broad array of rotors and ... and microplate applications, the IEC CL40 ...
... CL40 and FL40 Centrifuge Series from ... versatility to increase your productivity in ... array of rotors and accessories for ... applications, the IEC CL40 and FL40 ...
... IEC CL31 Multispeed Series offers unsurpassed ... quiet, compact, 1.2 liter benchtop centrifuge. ... and accessories and high-speed centrifugation capabilities, ... everything you need to meet a ...
Medicine Products: